Clinically, patients with BC were reported to overexpress DNMT1 compared to patients with breast fibroadenoma [14], and this overexpression was associated with BC development, while its downregulation inhibits proliferation and invasion of BC [11,12,13]. This evidence concerns the gene DNMT1 and breast cancer.